Itau Unibanco Holding S.A. Otonomy, Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.35 - $3.09 $6,283 - $8,262	-2,674 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$1.51 - $2.93 $801 - $1,555	-531 Reduced 16.57%	2,674 $5,000
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.95 $213 - $323	-82 Reduced 2.49%	3,205 $9,000
Q2 2018 Aug 13, 2018	SELL	$3.7 - $4.75 $85 - $109	-23 Reduced 0.69%	3,287 $13,000
Q1 2018 May 14, 2018	BUY	$4.05 - $6.1 $9,513 - $14,328	2,349 Added 244.43%	3,310 $14,000
Q4 2017 Feb 09, 2018	BUY	$2.8 - $5.55 $336 - $666	120 Added 14.27%	961 $5,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $20.8 $2,691 - $17,492	841	841 $9,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.